Roche's Avastin (bevacizumab) plus chemotherapy receives FDA approval for platinum-sensitive recurrent ovarian cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced that the U.S. Food and Drug Administration (FDA) has approved Avastin® (bevacizumab), either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine chemotherapy, followed by Avastin alone, for the treatment of patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. (Source: World Pharma News)
Source: World Pharma News - December 9, 2016 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news
Roche ’s Avastin (bevacizumab) plus chemotherapy receives FDA approval for platinum-sensitive recurrent ovarian cancer
Roche today announced that the U.S. Food and Drug Administration (FDA) has approved Avastin ® (bevacizumab), either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine chemotherapy, followed by Avastin alone, for the treatment of patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. (Source: Roche Investor Update)
Source: Roche Investor Update - December 7, 2016 Category: Pharmaceuticals Source Type: news
Roche ’s Avastin (bevacizumab) plus chemotherapy receives FDA approval for platinum-sensitive recurrent ovarian cancer
Roche today announced that the U.S. Food and Drug Administration (FDA) has approved Avastin ® (bevacizumab), either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine chemotherapy, followed by Avastin alone, for the treatment of patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. (Source: Roche Media News)
Source: Roche Media News - December 7, 2016 Category: Pharmaceuticals Source Type: news
I am a Hypochondriac
I am in a perpetual abusive relationship with hypochondria; I desperately want to get away from it, but somehow it controls my brain.
I've had hypochondriac tendencies (more officially known as "illness anxiety disorder") for as long as I can remember. I'm not sure who or what to blame and the source of the disorder is irrelevant; it's the cure I'm after.
Hypothesis theories for my hypochondria:
Throughout my childhood, my mother perpetually complained of a bad heart and threatened to faint, falling back on her stash of smelling salts in her purse.
The best birthday present I ever got was the Merck Medical Manual, whic...
Source: Healthy Living - The Huffington Post - September 30, 2016 Category: Consumer Health News Source Type: news
The 1 Thing You Need To Stop Doing To Your Vagina
For SELF, by Zahra Barnes.
A scary new report adds one more item to the “why women shouldn’t douche” list.
Gynecologists have been telling their patients not to clean their vaginas with douches for years—and now they have yet another strong point against it: The practice is associated with nearly a doubled risk of getting ovarian cancer, according to a large study from the National Institute of Environmental Health Sciences.
“Douching is just wrong,” Sherry Ross, M.D., an ob/gyn and women’s health expert at Providence Saint John’s Health Center in Santa M...
Source: Healthy Living - The Huffington Post - August 16, 2016 Category: Consumer Health News Source Type: news
Stealthy early-stage NVision Medical raises $6.5m
Stealthy NVision Medical raised $6.5 million in a new round of equity financing to support its ovarian cancer diagnostic device, according to an SEC filing.
NVision is an early-stage medical device company focused on women’s health, specifically creating in-office diagnostics for ovarian cancer and fallopian tube blockages, according to a 2014 interview with MedCity News.
The company was incorporated in 2009, is based in San Francisco, Calif., and is run by founder and CEO Surbhi Sarna.
Money in the round came from 17 unnamed sources, and the company is still looking for another $5.5 million before closing, according to ...
Source: Mass Device - July 22, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Women's Health NVision Source Type: news
BRCA1 mutations linked to increased risk of serous, serous-like endometrial cancer
(The JAMA Network Journals) Increased risk for aggressive serous/serous-like endometrial cancer was increased in women with BRCA1 mutations, although the overall risk for uterine cancer after risk-reducing salpingo-oophorectomy (RRSO) to remove the fallopian tube and ovary was not increased, according to a new study published online by JAMA Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2016 Category: Cancer & Oncology Source Type: news
Research uncovers more inherited genetic mutations linked to ovarian cancer
(Care New England ) Previous research has established a link between genetic mutations in the BRCA1 and BRCA2 genes to an increased risk of developing ovarian, fallopian tube or peritoneal cancer in women. A recent publication documents the efforts of a team of researchers affiliated with the Gynecologic Oncology Group (GOG) to determine if inherited genetic mutations other than BRCA1 and BRCA2 can also put a woman at risk of developing these diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 10, 2016 Category: Cancer & Oncology Source Type: news
Fallopian tube organoids promise better understanding of ovarian cancer, infertility
A new way of growing fallopian tube cells in culture is expected to give a boost to our understanding and prevention of female genital diseases, such as infertility, inflammatory disease, and ovarian cancer. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 11, 2015 Category: Science Source Type: news
Fallopian tube organoids promise better understanding of ovarian cancer and infertility
(Max-Planck-Gesellschaft) A new way of growing Fallopian tube cells in culture is expected to give a boost to our understanding and prevention of female genital diseases, such as infertility, inflammatory disease, and ovarian cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2015 Category: Global & Universal Source Type: news
That Time My Ovary Grew Something It Shouldn't, Twice
I felt it jolt me awake and suddenly I knew I couldn't really move. My stomach was clenched tight from the stabbing sensation, my legs were curled, and I laid there in a fetal position in our bed waking my fiancé up with my groaning. "Do you need a Gas X again or suppository? I told you not to eat all that ice cream," she mumbled half-asleep like she's had to every other night for years because I'm a stubborn fat ass. Though it was very possible Chocolate Malted Crunch was to blame, something told me it was something else. And I was right. Later at the hospital that day, we learned I had ruptured an ovarian cyst on my ri...
Source: Science - The Huffington Post - December 3, 2015 Category: Science Source Type: news
Olivia Key who looked pregnant discovers a cancerous cyst is to blame
Olivia Key, 18, of Hull, had surgery to remove the cancerous ovarian cyst, which weighed one and a half stone - heavier than a newborn baby. She also had her ovary and fallopian tube removed. (Source: the Mail online | Health)
Source: the Mail online | Health - December 3, 2015 Category: Consumer Health News Source Type: news
Leeds girl astonished when tests reveal a 30cm cyst and ovarian cancer
Olivia Key, now 18, from Hull, was rushed into surgery at St James's Hospital in Leeds where medics removed the growth as well as her ovary and fallopian tube. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2015 Category: Consumer Health News Source Type: news
New method enables the early detection of ovarian cancer
Around 75 per cent of ovarian tumors arise from the fallopian tube. There are currently no options for detecting this condition early or preventing it. With the help of an innovative, "three-way" catheter, a new study suggests that this situation may be different in the future. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 10, 2015 Category: Science Source Type: news
Maidstone woman who doctors believed was pregnant had cancerous tumour
Louise Bryant, 26, of Maidstone, had an immature teratoma, a rare type of ovarian cancer. She underwent a four hour operation to remove the 20cm growth and her fallopian tube. (Source: the Mail online | Health)
Source: the Mail online | Health - July 20, 2015 Category: Consumer Health News Source Type: news
